S&P ASX All Technology

3,104.50

-1.06%

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Anormed Ord (MM) (ANOR)
Anormed Ord (MM) (ANOR) News

ANOR

Anormed Ord (MM) (ANOR)

Anormed Ord (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANOR

1

Date	Time	Source	Headline	Symbol	Company
08/11/2006	08:57	PR Newswire (US)	Genzyme Completes Tender Offer for Outstanding Shares of AnorMED	NASDAQ:ANOR
07/11/2006	16:01	PR Newswire (US)	Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review	NASDAQ:ANOR
03/11/2006	16:05	PR Newswire (US)	AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events	NASDAQ:ANOR
03/11/2006	16:05	PR Newswire (US)	AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events	NASDAQ:ANOR
27/10/2006	00:00	PR Newswire (US)	Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer	NASDAQ:ANOR	Anormed Ord (MM)
24/10/2006	00:00	PR Newswire (US)	AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule	NASDAQ:ANOR
18/10/2006	00:47	PR Newswire (US)	AnorMED and Genzyme reach agreement on acquisition	NASDAQ:ANOR
12/10/2006	12:03	PR Newswire (US)	AnorMED has determined Genzyme's offer is a 'superior proposal'	NASDAQ:ANOR
12/10/2006	11:47	PR Newswire (US)	AnorMED has determined Genzyme's offer is a 'superior proposal'	NASDAQ:ANOR
11/10/2006	14:30	PR Newswire (US)	AnorMED announces receipt of proposal from Genzyme Corporation	NASDAQ:ANOR
11/10/2006	14:30	PR Newswire (US)	AnorMED announces receipt of proposal from Genzyme Corporation	NASDAQ:ANOR
11/10/2006	00:50	PR Newswire (US)	Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash	NASDAQ:ANOR
07/10/2006	02:41	PR Newswire (US)	Genzyme Extends Deadline for Tender Offer to Acquire AnorMED Inc.	NASDAQ:ANOR	Anormed Ord (MM)
06/10/2006	13:10	PR Newswire (US)	AnorMED Board recommends shareholders accept Millennium offer	NASDAQ:ANOR
06/10/2006	13:10	PR Newswire (US)	AnorMED Board recommends shareholders accept Millennium offer	NASDAQ:ANOR
05/10/2006	14:36	PR Newswire (US)	AnorMED board continues to recommend that shareholders accept Millennium's planned tender offer	NASDAQ:ANOR
27/09/2006	00:46	PR Newswire (US)	Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date	NASDAQ:ANOR
27/09/2006	00:45	PR Newswire (US)	AnorMED agrees to support a planned tender offer of US$12 per share from Millennium Pharmaceuticals	NASDAQ:ANOR
25/09/2006	15:23	PR Newswire (US)	Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED	NASDAQ:ANOR
21/09/2006	00:00	PR Newswire (US)	AnorMED reports on Annual General Meeting	NASDAQ:ANOR
19/09/2006	22:30	PR Newswire (US)	AnorMED amends license agreement for cancer drug	NASDAQ:ANOR
19/09/2006	22:30	PR Newswire (US)	Poniard Pharmaceuticals Expands Picoplatin Agreement to Include Exclusive Worldwide Rights and Improved Financial Terms and Cond	NASDAQ:ANOR
19/09/2006	00:00	PR Newswire (US)	Approval of FOSRENOL in Germany triggers U.S.$3 million payment to AnorMED	NASDAQ:ANOR
16/09/2006	11:22	PR Newswire (US)	AnorMED Provides Update on Limited Duration Shareholder Rights Plan	NASDAQ:ANOR
13/09/2006	03:57	PR Newswire (US)	Atticus Capital LP Opposes Genzyme bid for AnorMED	NASDAQ:ANOR